Overview

PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the effect of Propionyl-L-Carnitine Hydrochloride on clinical pharmacokinetic characteristics and its effect of clinical pharmacokinetic characteristics and safety on healthy Chinese subjects to provide a basis for market authorization registration
Phase:
Phase 1
Details
Lead Sponsor:
Lee's Pharmaceutical Limited